Integrated REMS and Patient Support Services Solution for Complex Rare Disease

Download our integrated Risk Evaluation and Mitigation Strategy (REMS) and Patient Support Program case study for unique experience with chronic treatment management and regulatory requirements of a complex rare disease.

Discover how UBC has been the single point of contact for over 10 years to reduce program risk and burden through multiservice governance for 28,000 patients.

Our leading team of REMS experts helped our pharmaceutical sponsor easily maneuver through complicated rare disease challenges, including:     

• FDA requirement for a REMS
• Specialized approach to stakeholder involvement
• High cost and complex payer coverage

Learn how our highly functional REMS solution has simplified enrollment processes, monitored for compliance, and provided quick and ongoing stakeholder support.

Simply complete the form to the right to read the full REMS and Patient Support Program case study.

UBC is the leading provider of risk management and REMS services. Our REMS consultation, design, and implementation aim to reduce stakeholder burden, minimize barriers to access, and ensure product safety and value.